Crossmark

Liraglutide in a real-world setting: Joint modeling of metabolic response, prediction of efficacy, and cardiovascular risk

Crossref DOI link: https://doi.org/10.1016/j.endien.2019.06.001

Published Print: 2019-06

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Alonso-Troncoso, Isabel

Carollo-Limeres, Carmen

Rios-Prego, Mónica

Guler, Ipek

Cadarso-Suárez, Carmen

F-Mariño, Alexis
Funding

Funding for this research was provided by:

Novo Nordisk
License Information

Text and Data Mining valid from 2019-06-01
More Information

This article is maintained by: Elsevier

Article Title: Liraglutide in a real-world setting: Joint modeling of metabolic response, prediction of efficacy, and cardiovascular risk

Journal Title: Endocrinología, Diabetes y Nutrición (English ed.)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.endien.2019.06.001

Content Type: article

Copyright: © 2018 SEEN and SED. Published by Elsevier España, S.L.U. All rights reserved.